A Study to Confirm if Fezolinetant Helps Reduce Hot Flashes in Women With Breast Cancer Who Are Having Hormone Therapy
Clinical trial NCT06440967 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06440967
- Sponsor
- Astellas Pharma Global Development, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-31
- Primary completion
- 2026-06-30
- Enrollment
- 982
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.